Ledger.Open graph →
SEC Form D · Amendment · filed October 22, 2015

Tocagen Inc

Offering
$50.4M
Sold
$46.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Dennis Berman · San Diego, CAExec · DirectorPaul R. Schimmel · San Diego, CADirectorDouglas Jolly · San Diego, CAExecThomas Darcy · San Diego, CAExec · DirectorFaheem M. Hasnain · San Diego, CADirectorDavid R. Parkinson · San Diego, CADirectorLori R. Kunkel · San Diego, CADirectorFranklin M. Berger · San Diego, CADirectorHarry Gruber · San Diego, CAExec · DirectorWilliam J. Anderson · Toronto, Ontario, Z4DirectorRick H. Walsh · Orlando, FLExec · DirectorVictory Road Investors, LLC · North Quincy, MADirectorMaxwell E. A · Maitland, FLExecMichael A. Okaty · Orlando, FLDirectorMorey H. Goldberg · Wynnewood, PADirectorTerry Girling · Nassau, C5DirectorRenato A. Mazzolini · Nassau, C5Exec · DirectorBarry Lieberman · Santa Barbara, CAExec · DirectorEli Aizenstat · Santa Barbara, CAExec · DirectorDavid J. Blumberg · San Francisco, CADirectorMark A. Allen · Cambridge, MADirectorJenny Abramson · White Plains, NYExec · DirectorChristopher A. Mccain · Cambridge, MAExec · DirectorSteve C. Owen · Austin, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗